<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26173602</article-id>
      <article-id pub-id-type="pmc">4502560</article-id>
      <article-id pub-id-type="publisher-id">332</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0332-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Thymic lymphoid hyperplasia with multilocular thymic cysts diagnosed before the Sj&#xF6;gren syndrome diagnosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Minato</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <address>
            <phone>81-76-218-8017</phone>
            <email>hminato@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kinoshita</surname>
            <given-names>Eriko</given-names>
          </name>
          <address>
            <email>ekino@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakada</surname>
            <given-names>Satoko</given-names>
          </name>
          <address>
            <email>snakada@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nojima</surname>
            <given-names>Takayuki</given-names>
          </name>
          <address>
            <email>nojima@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Makoto</given-names>
          </name>
          <address>
            <email>dr-ryo@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Usuda</surname>
            <given-names>Katsuo</given-names>
          </name>
          <address>
            <email>usuda@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sagawa</surname>
            <given-names>Motoyasu</given-names>
          </name>
          <address>
            <email>sagawam@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iwao</surname>
            <given-names>Haruka</given-names>
          </name>
          <address>
            <email>iwaharu@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Masao</given-names>
          </name>
          <address>
            <email>masatana@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Doai</surname>
            <given-names>Mariko</given-names>
          </name>
          <address>
            <email>doaimari@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takahashi</surname>
            <given-names>Tomoko</given-names>
          </name>
          <address>
            <email>tomoko-t@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shibata</surname>
            <given-names>Naoko</given-names>
          </name>
          <address>
            <email>n-shiba@kanazawa-med.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology and Laboratory Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 9200293 Japan </aff>
        <aff id="Aff2"><label/>Department of Thoracic Surgery, Kanazawa Medical University, Uchinada, Ishikawa Japan </aff>
        <aff id="Aff3"><label/>Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa Japan </aff>
        <aff id="Aff4"><label/>Department of Radiology, Kanazawa Medical University, Uchinada, Ishikawa Japan </aff>
        <aff id="Aff5"><label/>Department of Ophthalmology, Kanazawa Medical University, Uchinada, Ishikawa Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>103</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Minato et al. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Thymic lymphoid hyperplasia is often present with myasthenia gravis as well as other autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Of the 4 cases of thymic lymphoid hyperplasia associated with Sj&#xF6;gren syndrome that have been reported, no case with a thymic lesion diagnosis that led to the diagnosis of Sj&#xF6;gren syndrome has been reported. We herein report a case of thymic lymphoid hyperplasia with multilocular thymic cysts, diagnosed before Sj&#xF6;gren syndrome.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 37-year-old Japanese woman had an approximate 5-cm anterior mediastinal mass detected by chest imaging. The resected lesion revealed multilocular thymic cysts that were filled with colloid-like material. Histology showed lymph follicular hyperplasia with many epithelial cysts. The epithelium consisted of thymic medullary epithelium, and no epithelial proliferation was seen in the lymphoid tissue. Lymphocytes were composed of an organized mixed population of mature T and B cells without significant atypia. The infiltrated B cells did not reveal light chain restriction or immunoglobulin heavy chain gene rearrangement. After the pathological diagnosis of thymic lesion, tests for the presence of autoantibodies were positive for antinuclear antibodies, rheumatic factor, and anti-SSA/Ro antibodies. The Schirmer&#x2019;s, chewing gum, and Saxon tests showed decreased salivary and lacrimal secretion. Lip biopsy showed focal lymphocytic sialadenitis. The signs and symptoms of Sj&#xF6;gren syndrome had not resolved, without aggravation, 1&#xA0;year after the thymectomy.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>When a case with thymic lymphoid hyperplasia without myasthenia gravis is encountered, it is essential to consider the presence of another autoimmune disease including Sj&#xF6;gren syndrome.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Thymus</kwd>
        <kwd>Multilocular thymic cysts</kwd>
        <kwd>Lymphoid hyperplasia</kwd>
        <kwd>Follicular hyperplasia</kwd>
        <kwd>Sj&#xF6;gren syndrome</kwd>
        <kwd>Immunohistochemistry</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Thymic lesions in Sj&#xF6;gren syndrome primarily consist of extranodal marginal zone B-cell (MALT) lymphoma and rarely consist of thymoma, thymic carcinoma, or lymphoid hyperplasia [<xref ref-type="bibr" rid="CR1">1</xref>]. Of the 4 cases with thymic lymphoid hyperplasia associated with Sj&#xF6;gren syndrome that have been reported [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>], 3 cases were accompanied by multilocular thymic cysts. We herein report a case of thymic lymphoid hyperplasia with multilocular thymic cysts that led to the diagnosis of preclinical Sj&#xF6;gren syndrome. To the best of our knowledge, a diagnosis of thymic lymphoid hyperplasia before the diagnosis of Sj&#xF6;gren syndrome has not previously been reported.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 37-year-old Japanese woman was referred to our hospital for general malaise. Chest radiography, computed tomography (CT), and magnetic resonance imaging revealed a superior anterior mediastinal tumor that was 4.7&#x2009;&#xD7;&#x2009;3.8&#x2009;&#xD7;&#x2009;2.8&#xA0;cm in size, with multilocular cysts. CT with contrast enhancement showed mild enhancement of the septum of the lesion&#xA0;(Fig. <xref rid="Fig1" ref-type="fig">1a</xref>-<xref rid="Fig1" ref-type="fig">c</xref>). T1-weighted and T2-weighted images revealed isointensity and high intensity, respectively, of the lesion&#xA0;(Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). Calcification or fatty components were not seen. The positron emission tomography standardized uptake value (PET SUVmax) was 4.25, which was relatively low&#xA0;(Fig. <xref rid="Fig1" ref-type="fig">1e</xref>). The following tumor markers were all within normal range: carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma antigen, CYFRA 21&#x2013;1, sialyl Lewis X, and progastrin-releasing peptide. Anti-acetylcholine receptor antibodies were not detected. Thymoma, thymic cyst, or teratoma was suspected, and a thymectomy was performed. After the pathological diagnosis, on suspicion of an associated autoimmune disease, autoantibodies were examined and were positive for antinuclear antibodies (speckled type, &#xD7;640), rheumatic factor (114; normal range &lt;15&#xA0;IU/mL), and anti-SSA/Ro antibodies (&gt;240; normal &lt;10 U/mL) and negative for anti-SS-B/La, anti-DNA, anti-RNP, anti-Sm, anti-cyclic citrullinated peptide, Jo-1, Scl-70, and anti-neutrophil cytoplasmic antibodies (MPO-ANCA and PR3-ANCA). She also had a mildly dry mouth and dry eyes. The Schirmer&#x2019;s (right 2&#xA0;mm/left 2&#xA0;mm), chewing gum (2.9&#xA0;mL/10&#xA0;min), and Saxon (0.62&#xA0;g/2&#xA0;min) tests all showed decreased secretion of the lacrimal and salivary glands. A lip biopsy specimen revealed focal lymphocytic sialadenitis. Based on these findings, Sj&#xF6;gren syndrome was diagnosed. The signs and symptoms of Sj&#xF6;gren syndrome, without aggravation, were not resolved 1&#xA0;year after the thymectomy, and autoantibody titers did not show remarkable changes.<fig id="Fig1"><label>Fig. 1</label><caption><p>Radiological imaging of the lesion. Contrast-enhancement computed tomography (CT) shows a tumor in the superior anterior mediastinum with slightly enhanced multiple septa (<bold>a</bold>-<bold>c</bold>). Magnetic resonance imaging (MRI) with fat suppression reveals the tumor with high-intensity (<bold>d</bold>). The standardized uptake value (SUVmax) of positron emission tomography (PET)-CT was 4.25, which was relatively low (<bold>e</bold>)</p></caption><graphic xlink:href="13000_2015_332_Fig1_HTML" id="MO1"/></fig></p>
      <sec id="Sec3">
        <title>Pathological findings</title>
        <p>The resected thymectomy specimen was 9.5&#x2009;&#xD7;&#x2009;5.5&#x2009;&#xD7;&#x2009;2.5&#xA0;cm in size and weighed 61&#xA0;g. An ill-defined elastic firm mass, 5&#x2009;&#xD7;&#x2009;3.5&#x2009;&#xD7;&#x2009;2.5&#xA0;cm in size, was found in the thymus with multilocular cysts, many of which were filled with yellowish-green colloid-like material&#xA0;(Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Histology of the tumor revealed lymphoid tissue with hyperplastic germinal centers and occasional Hassall corpuscles&#xA0;(Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The cysts were lined by thin layers of thymic epithelium&#xA0;(Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Outside the tumor in the thymus, there were many small nodules of lymphoid tissue showing similar morphology as the main tumorous lesion. In the small nodules of lymphoid tissue, microscopic cysts lined by thymic epithelium were occasionally found&#xA0;(Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The lymphocytes were small and mature except for cells in germinal centers. No significant atypia was seen in the lymphoid and epithelial cells. Immunohistochemically, cytokeratin AE1/AE3 highlighted the epithelium of the cysts and Hassall corpuscles&#xA0;(Fig. <xref rid="Fig6" ref-type="fig">6</xref>). There was no epithelial proliferation in the nodular lymphoid tissue; the findings eliminated the possibility of thymoma. Lymphoid markers revealed organized mixed distribution of CD3+, CD5+, CD20+, and CD79+ cells and did not show monoclonal proliferation of B cells or T cells&#xA0;(Fig. <xref rid="Fig7" ref-type="fig">7a</xref>,<xref rid="Fig7" ref-type="fig">b</xref>). Immunostaining of light chains showed that the approximate ratio of kappa to lambda was 3:1, and no significant light chain restriction was seen&#xA0;(Fig. <xref rid="Fig7" ref-type="fig">7c</xref>,<xref rid="Fig7" ref-type="fig">d</xref>). Staining of immunoglobulin (Ig)G, IgA, and IgM heavy chains did not reveal monoclonal proliferation. Both CD20&#x2009;+&#x2009;B cells and CD3&#x2009;+&#x2009;T cells infiltrated the epithelium. No aberrant expression of CD5 and CD43 B cells was observed. Bcl-2 was negative in the germinal center of lymphoid follicles. Polymerase chain reaction and gene analysis from the formalin-fixed paraffin embedded tissue of the lesion did not show rearrangement of the immunoglobulin heavy chain (IgH) gene. Thymic lymphoid hyperplasia with multilocular thymic cysts was the pathological diagnosis.<fig id="Fig2"><label>Fig. 2</label><caption><p>Macroscopic findings of the thymic tumor. An ill-defined tumor (5&#x2009;&#xD7;&#x2009;3.5&#x2009;&#xD7;&#x2009;2.5&#xA0;cm) is seen in the upper part of the resected thymus (<italic>arrow</italic>) (<bold>a</bold>). The cut surface shows a multicystic tumor filled with yellowish-green colloid-like material (<bold>b</bold>)</p></caption><graphic xlink:href="13000_2015_332_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Histological findings of the thymic tumor. Lower power view shows the cystic walls are composed mostly of lymphoid tissue with epithelial linings. Cysts are filled with eosinophilic proteinous secretion containing cholesterol clefts</p></caption><graphic xlink:href="13000_2015_332_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Histologic findings of the cyst wall. Higher power view reveals that the cyst wall consists of mature small lymphocytes with a germinal center (<italic>right lower</italic>) and thymic medullary epithelium with Hassall corpuscles</p></caption><graphic xlink:href="13000_2015_332_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Histological findings of the thymus. Non-tumorous thymic tissue also shows hyperplastic lymphoid tissue with many germinal centers. Occasionally, microscopic cystic lesions (<italic>right upper</italic>) similar to the tumorous lesion are seen in the thymus</p></caption><graphic xlink:href="13000_2015_332_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Immunohistochemical findings of the epithelial marker. Immunohistochemistry of cytokeratin AE1/AE3 highlights the organized network of the thymic medullary epithelium surrounding hyperplastic lymphoid tissue. No epithelial proliferation is seen in the nodular lymphoid tissue</p></caption><graphic xlink:href="13000_2015_332_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>Immunohistochemical findings of the lymphoid markers. Immunohistochemistry of CD3 (<bold>a</bold>) and CD20 (<bold>b</bold>) shows mixed distribution of T and B cells and does not show any monoclonal proliferation. Both CD20&#x2009;+&#x2009;B cells and CD3+ T cells infiltrate the lining epithelium of the cyst. Immunostaining of light chains (<bold>c</bold>, <bold>d</bold>) does not show restriction of kappa (<bold>c</bold>) or lambda (<bold>d</bold>) chains</p></caption><graphic xlink:href="13000_2015_332_Fig7_HTML" id="MO7"/></fig></p>
        <p>The lip biopsy specimen revealed mild atrophy of the minor salivary glands with mild fibrosis and focal lymphoid aggregation&#xA0;(Fig. <xref rid="Fig8" ref-type="fig">8</xref>). A lymphoepithelial lesion was not seen. The focus score [<xref ref-type="bibr" rid="CR4">4</xref>] was 1.25 and was graded [<xref ref-type="bibr" rid="CR5">5</xref>] as 4.<fig id="Fig8"><label>Fig. 8</label><caption><p>Histological findings of the minor salivary gland. Histology of the labial minor salivary gland shows focal lymphocytic aggregation in the gland with mild glandular atrophy. A lymphoepithelial lesion is not seen. The focus score was 1.25 and was graded as 4</p></caption><graphic xlink:href="13000_2015_332_Fig8_HTML" id="MO8"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec4" sec-type="discussion">
      <title>Discussion</title>
      <p>To the best of our knowledge, this is the first report of thymic lymphoid hyperplasia that led to the diagnosis of preclinical Sj&#xF6;gren syndrome. The lesion was accompanied by multilocular thymic cysts.</p>
      <p>Thymic cysts are categorized as either congenital and acquired; the former is usually unicystic and non-inflammatory, and the latter is generally multicystic and associated with other diseases such as thymoma, thymic carcinoma, malignant lymphoma including MALT lymphoma, Hodgkin lymphoma, germ cell tumor, HIV infection, or lymphoid hyperplasia [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Both unicystic and multicystic lesions are lined with flattened, cuboidal, ciliated columnar or stratified squamous epithelium, but multilocular thymic cysts are most likely the result of cystic transformation of medullary epithelium induced by an acquired inflammatory process [<xref ref-type="bibr" rid="CR6">6</xref>]. The microscopic cysts found in the non-tumorous area of the present case suggest the beginning of such an acquired process.</p>
      <p>Although the occurrence of thymic lymphoid hyperplasia is relatively rare, it is most commonly associated with myasthenia gravis (MG). Aside from MG, thymic lymphoid hyperplasia is most often accompanied with other autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, scleroderma, Sj&#xF6;gren syndrome, allergic vasculitis, and Hashimoto thyroiditis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In contrast to true thymic hyperplasia, thymic lymphoid hyperplasia usually does not show thymic enlargement but an increased number of lymphoid follicles [<xref ref-type="bibr" rid="CR7">7</xref>]. Numerous hyperplastic germinal centers with tingible body macrophages and centroblastic and centrocytic cells are usually present [<xref ref-type="bibr" rid="CR8">8</xref>]. The mantle zone is well defined, while the marginal zone is not developed. A normal thymic cortex is observed around the areas of lymphoid hyperplasia, and effacement of the thymic architecture with cortical atrophy is not seen. Differentiation from MALT lymphoma, Castleman disease, and lymphocyte predominant thymoma (type B1) is important.</p>
      <p>In MALT lymphoma, interfollicular expansion of centrocyte-like cells, monocytoid B-cells, or plasmacytoid cells fill the medullary spaces and partially infiltrate reactive follicles (follicular colonization) with atrophic mantle zones. Nuclei of infiltrating lymphocytes are irregular with dense chromatin and occasional blastoid larger cells. These findings were not observed in the present case. Furthermore, each follicle is not surrounded by an epithelial network, as observed in the present case, and invasion of monocytoid B-cells or centrocyte-like lymphocytes with irregular nuclei are observed in MALT lymphoma. The present case did not have monoclonal proliferation of lymphocytes and plasma cells, and the genetic analysis from the formalin-fixed paraffin embedded tissue of the lesion did not show rearrangement of the IgH gene.</p>
      <p>A hyaline vascular type of Castleman disease typically shows germinal centers containing a few small vessels bridging through to perifollicular tissue and is surrounded by concentrically arranged small lymphoid cells, whereas a plasma cell type shows diffuse sheet-like infiltration of plasma cells in the interfollicular zone. The present case did not show the typical histopathological changes of either type of Castleman disease.</p>
      <p>A literature search in the PubMed database resulted in 22 cases of MALT lymphoma, 6 cases of thymoma, 4 cases of lymphoid hyperplasia, and 1 case of thymic carcinoma associated with Sj&#xF6;gren syndrome. Of the 4 cases of thymic lymphoid hyperplasia associated with Sj&#xF6;gren syndrome [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>], 3 cases were accompanied by multilocular thymic cysts [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. To the best of our knowledge, a diagnosis of thymic lymphoid hyperplasia before the Sj&#xF6;gren syndrome diagnosis has not been reported previously. Although the preoperative signs and symptoms were mild, the patient fulfilled the criteria of primary Sj&#xF6;gren syndrome [<xref ref-type="bibr" rid="CR9">9</xref>], including decreased secretion of the lacrimal and salivary glands, presence of autoantibodies to SSA/Ro, and a focus score &gt;1 for the lip biopsy [<xref ref-type="bibr" rid="CR10">10</xref>]. The patient had no history of other collagen vascular diseases, radiation therapy, hepatitis C infection, acquired immunodeficiency disease, malignant lymphoma, sarcoidosis, graft-versus-host disease, or use of anticholinergic drugs.</p>
      <p>Although thymectomy leads to remission in a significant number of MG patients with thymic lymphoid hyperplasia [<xref ref-type="bibr" rid="CR11">11</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>], the disease outcome differs [<xref ref-type="bibr" rid="CR11">11</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>], especially in those with different types of autoantibodies [<xref ref-type="bibr" rid="CR11">11</xref>]. Thymectomy did not appear to improve the sicca symptoms or to decrease the serum level of anti-SSA/Ro antigens in the present patient. Izumi, et al. [<xref ref-type="bibr" rid="CR1">1</xref>] reported that the serum ANA levels remained high after thymectomy in two patients with Sj&#xF6;gren syndrome and thymic follicular hyperplasia, although without aggravation of their condition. We do not know which came first, the thymic lesion or Sj&#xF6;gren syndrome. Based on the experience of these few cases, Sj&#xF6;gren syndrome might develop first. However, even if the thymic lesion develops first, resection of thymic lesions might not improve, or only gradually improve, the autoimmune diseases that show poor response to corticosteroids, when compared with MG [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
    </sec>
    <sec id="Sec5" sec-type="conclusion">
      <title>Conclusions</title>
      <p>We report a case of thymic lymphoid hyperplasia with multilocular thymic cysts, which led to the diagnosis of preclinical Sj&#xF6;gren syndrome. When we encounter a case with thymic lymphoid hyperplasia, we should consider the presence of autoimmune diseases. The precise mechanism underlying the association between Sj&#xF6;gren syndrome and thymic lesions is yet to be determined.</p>
    </sec>
    <sec id="Sec6">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>MALT lymphoma</term>
          <def>
            <p>Extranodal marginal zone B-cell lymphoma</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>Computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>PET SUVmax</term>
          <def>
            <p>Positron emission tomography standardized uptake values</p>
          </def>
        </def-item>
        <def-item>
          <term>Ig</term>
          <def>
            <p>Immunoglobulin</p>
          </def>
        </def-item>
        <def-item>
          <term>IgH</term>
          <def>
            <p>Immunoglobulin heavy chain</p>
          </def>
        </def-item>
        <def-item>
          <term>MG</term>
          <def>
            <p>Myasthenia gravis</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>HM drafted the report, contributed to the study conception and design, acquisition of data, and analysis and interpretation of data. EK, SN, and TN contributed to acquisition of pathological data and diagnosis and were involved in critically revising the manuscript for important intellectual content. MT, KU, MS, HI, MT, and NS cared for the patient and contributed to acquisition of clinical data. MD and TT contributed to acquisition and interpretation of the radiological imaging data. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgement</title>
      <p>Authors specially thank to Mrs. Asami Nakayama for her technical assistance. This study was supported in part by JSPS KAKENHI Grant Number 26460660 (H. M.).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Izumi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nobukawa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kumasaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multilocular thymic cyst associated with follicular hyperplasia: clinicopathologic study of 4 resected cases</article-title>
          <source>Hum Pathol</source>
          <year>2005</year>
          <volume>36</volume>
          <fpage>841</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2005.05.004</pub-id>
          <pub-id pub-id-type="pmid">16084956</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ozeki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aida</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary and thymic lymphoid hyperplasia in primary Sjogren&#x2019;s syndrome</article-title>
          <source>Jpn J Radiol</source>
          <year>2009</year>
          <volume>27</volume>
          <fpage>107</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1007/s11604-008-0298-8</pub-id>
          <pub-id pub-id-type="pmid">19373541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kondo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakiyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shimosato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Monden</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Multilocular thymic cyst associated with Sjogren&#x2019;s syndrome</article-title>
          <source>Ann Thorac Surg</source>
          <year>2001</year>
          <volume>72</volume>
          <fpage>1367</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-4975(00)02706-5</pub-id>
          <pub-id pub-id-type="pmid">11603465</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenspan</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Talal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sylvester</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>The histopathology of Sjogren&#x2019;s syndrome in labial salivary gland biopsies</article-title>
          <source>Oral Surg Oral Med Oral Pathol</source>
          <year>1974</year>
          <volume>37</volume>
          <fpage>217</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1016/0030-4220(74)90417-4</pub-id>
          <pub-id pub-id-type="pmid">4589360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chisholm</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Labial salivary gland biopsy in Sjogren&#x2019;s disease</article-title>
          <source>J Clin Pathol</source>
          <year>1968</year>
          <volume>21</volume>
          <fpage>656</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.21.5.656</pub-id>
          <pub-id pub-id-type="pmid">5697370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suster</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Multilocular thymic cyst: an acquired reactive process. Study of 18 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1991</year>
          <volume>15</volume>
          <fpage>388</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199104000-00008</pub-id>
          <pub-id pub-id-type="pmid">2006719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Shimosato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsuno</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Silverberg</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Lymphoid hyperplasia</article-title>
          <source>Tumors of the Mediasinum</source>
          <year>2010</year>
          <publisher-loc>Washington, D.C.</publisher-loc>
          <publisher-name>American Registry of Pathology</publisher-name>
          <fpage>276</fpage>
          <lpage>80</lpage>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parrens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dubus</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Danjoux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jougon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brousset</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Velly</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mucosa-associated lymphoid tissue of the thymus hyperplasia vs lymphoma</article-title>
          <source>Am J Clin Pathol</source>
          <year>2002</year>
          <volume>117</volume>
          <fpage>51</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1309/G3AC-P7K8-2JNK-8C3U</pub-id>
          <pub-id pub-id-type="pmid">11789730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vitali</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bombardieri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moutsopoulos</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Carsons</surname>
              <given-names>SE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Classification criteria for Sjogren&#x2019;s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group</article-title>
          <source>Ann Rheum Dis</source>
          <year>2002</year>
          <volume>61</volume>
          <fpage>554</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.61.6.554</pub-id>
          <pub-id pub-id-type="pmid">12006334</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radfar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kleiner</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Pillemer</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers</article-title>
          <source>Arthritis Rheum</source>
          <year>2002</year>
          <volume>47</volume>
          <fpage>520</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1002/art.10668</pub-id>
          <pub-id pub-id-type="pmid">12382301</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nikolic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Djukic</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Basta</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hajdukovic</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stojanovic</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Stevic</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis</article-title>
          <source>Clin Neurol Neurosurg</source>
          <year>2013</year>
          <volume>115</volume>
          <fpage>432</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clineuro.2012.06.013</pub-id>
          <pub-id pub-id-type="pmid">22770539</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Budde</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Gal</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Mansour</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JI</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Predictors of outcome in thymectomy for myasthenia gravis</article-title>
          <source>Ann Thorac Surg</source>
          <year>2001</year>
          <volume>72</volume>
          <fpage>197</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-4975(01)02678-9</pub-id>
          <pub-id pub-id-type="pmid">11465178</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nieto</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Robledo</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Pajuelo</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Montes</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Giron</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases</article-title>
          <source>Ann Thorac Surg</source>
          <year>1999</year>
          <volume>67</volume>
          <fpage>1568</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-4975(99)00310-0</pub-id>
          <pub-id pub-id-type="pmid">10391256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mizumoto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takeoka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hishita</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MALT lymphoma of the thymus with Sjogren&#x2019;s syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy</article-title>
          <source>Int J Hematol</source>
          <year>2009</year>
          <volume>89</volume>
          <fpage>709</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1007/s12185-009-0324-3</pub-id>
          <pub-id pub-id-type="pmid">19430860</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
